ArticleFrontiers in pediatrics2025
Indocyanine green fluorescence in second-look surgery for necrotizing enterocolitis: enhancing the surgeon's perception.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Surgical Interventions for NEC-An Overview.Children (Basel, Switzerland) · 2026Review
- Current operative approaches for necrotizing enterocolitis.World journal of pediatric surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A perfusion mismatch in the premature gut is the key component in the development of necrotizing enterocolitis (NEC). Resulting necroses need to be surgically excised, while intestinal salvage is crucial to the survival and rehabilitation of affected preterm neonates. Until now, resection margins have been based on standard visual inspection and surgical experience due to the lack of objective criteria for bowel viability. We hypothesize that by evaluating the vitality and perfusion during NEC surgery, necrosis margins can reliably be defined by indocyanine green (ICG) fluorescent imaging, a real-time visualization method, which has already been implemented safely in pediatric surgery for other indications. Materials and methods: In a prospective study at our Level 1 Perinatal Center, patients were recruited after primary emergency surgery confirming NEC. Due to the acute phase of the inflammatory process, the extent and dynamics cannot be clearly defined at this point. Informed consent of the parents for the second-look surgery included ICG fluorescent imaging (0.04-0.7 mg/kg body weight), which was applied after completely exposing the intestinal bundle to visualize blood perfusion intraoperatively. ICG perfusion of intestinal tissue was visualized by a near-infrared camera and was compared with bowel vitality as judged conventionally by an experienced surgeon. Based on the findings, further treatment was specified. We correlated our surgical findings with subsequent histopathology. Results: Six patients treated at our perinatal center met the inclusion criteria. In four patients, ICG-negative, non-vital gut areas were detected and resected with narrow margins of <1 mm. Histology and the further medical course proved to be consistent with these intraoperative results. In two patients, the clinical appearance of complete necrosis of the small intestines was confirmed by ICG fluorescence, supporting the decision to provide palliative treatment. In two out of six patients, clinical judgment and real-time ICG fluorescence were contradictory. Here, histopathology confirmed complete necrosis of the bowel in full accordance with ICG. Conclusion: Our prospective cohort study gave evidence for ICG fluorescence to be useful and reliable in objectifying blood perfusion and intestinal vitality during NEC surgery, adding objectiveness to the surgeon's personal experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.